AJP - Heart Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 287: H2487-H2492, 2004; doi:10.1152/ajpheart.00462.2004
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Funabiki, K.
Right arrow Articles by Nakano, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Funabiki, K.
Right arrow Articles by Nakano, T.

Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure

Kaoru Funabiki,1 Katsuya Onishi,2 Kaoru Dohi,1 Takafumi Koji,1 Kyoko Imanaka-Yoshida,3 Masaaki Ito,1 Hideo Wada,2 Naoki Isaka,1 Tsutomu Nobori,2 and Takeshi Nakano1

1First Department of Internal Medicine, 2Department of Laboratory Medicine, and 3Department of Pathology, Mie University School of Medicine, Tsu 514-8507, Japan

Submitted 18 May 2004 ; accepted in final form 15 July 2004

Angiotensin receptor blocker (ARB) and angiotensin-converting enzyme (ACE) inhibitor (ACEI) each act in a different manner to prevent myocardial fibrosis and left ventricular (LV) stiffness in animals with pathways in the heart for generating ANG II as well as ACE. A model of pacing-induced congestive heart failure (CHF) was used to test the central hypothesis that ARB + ACEI prevents myocardial fibrosis and decreases LV stiffness to a greater extent than ARB or ACEI alone. Thirty-five dogs were assigned to the following treatment protocols on the 8th day of a 4-wk pacing schedule: 1) rapid ventricular pacing, 2) ARB (candesartan cilexetil, 1.5 mg·kg–1·day–1) with pacing, 3) ACEI (enalapril, 1.9 mg·kg–1·day–1) with pacing, 4) ARB (candesartan cilexetil, 0.75 mg·kg–1·day–1) + ACEI (enalapril, 0.95 mg·kg–1·day–1) with pacing, and 5) sham operation. The LV stiffness coefficient was significantly increased after rapid pacing but was significantly lower with ARB + ACEI than with ARB or ACEI alone. The collagen volume fraction and mRNA levels of collagen I and III, which were increased by rapid pacing, were significantly lower with ARB + ACEI than with ARB or ACEI alone. Thus ARB + ACEI prevents myocardial fibrosis and decreases LV stiffness during the progression of CHF compared with ARB or ACEI alone.

congestive heart failure; angiotensin II; collagen I and III; rapid pacing



Address for reprint requests and other correspondence: K. Onishi, Dept. of Laboratory Medicine, Mie Univ. School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan (E-mail: katsu{at}clin.medic.mie-u.ac.jp)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.